Stay ConnectedMacular Chats are a series of free, informative audio conversations hosted by Macular Degeneration Research, a BrightFocus Foundation program, featuring retina specialists and other eye care experts who will discuss various aspects of living with macular degeneration and geographic atrophy.
Topics will include macular degeneration treatments, remaining independent, and promising research on the horizon.
#Ophthalmology #Macular #MacularDegeneration #GeographicAtrophy #VisionLoss #LowVision
Copyright: © 2015 BrightFocus
The event featured Emily Chew, MD, Director of the Division of Epidemiology and Clinical Applications at the National Eye Institute. Dr. Chew shared the latest news on the role of nutritional supplements in age-related macular degeneration. Participants asked questions about how to know if they are purchasing the correct supplements and if AREDS2 can reverse vision damage.
The event featured Elin Schold Davis from the Older Driver Initiative, who provided information about diseases that cause vision issues or loss and the effects on driving. Many participants had questions and concerns about safe driving conditions, signs for concerns about driving, and how to transition to driving less.
This event featured Dr. Bonnielin Swenor, Ph.D., M.P.H., Director of the Johns Hopkins Disability Health Research Center, and an associate professor of ophthalmology at the Wilmer Eye Institute. She is also an associate professor of epidemiology at the Johns Hopkins Bloomberg School of Public Health, as well as a core faculty member at the Johns Hopkins Center on Aging and Health. Dr. Swenor discussed advancements in the field of vision research, the stigma and burden associated with vision loss, and the connection between vision health and cognitive health. Dr. Swenor also advocated for those with vision loss, stating the importance of society becoming more universally designed for those with vision loss.
The event featured Dr. David S. Liao, a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group who specializes in the medical and surgical treatment of diseases of the retina and vitreous. Dr. Liao discussed the latest treatments to manage dry AMD and geographic atrophy, recent clinical trials, ways to slow the progression of vision loss, and how to maintain and improve quality of life after the diagnosis of a vision loss disease.
Alan Glazier, OD, is an awarding-winning Maryland optometrist who discusses proper care for those diagnosed with age-related macular degeneration.
The discussion features Edward Marcus, MD, a leading ophthalmologist in New York. Dr. Marcus specializes in medical and surgical management of retinal diseases, including diabetic retinopathy, macular degeneration, and retinal detachment. He also specializes in treating inflammatory and infectious eye diseases.
Dr. Benjamin Kim is Assistant Professor of Ophthalmology at the Hospital of the University of Pennsylvania. His areas of research expertise include age-related macular degeneration, diabetic retinopathy, geographic atrophy, choroidal neovascularization, retinal neovascularization, clinical trials, and retinal imaging.
Ranjoo K. Prasad, O.D., a specialist in low vision rehabilitation at Penn Medicine, is the guest speaker.
The featured expert is Daniel Chao, MD, PhD, who is an Assistant Professor of Ophthalmology at the Shiley Eye Institute. He is a retina surgeon, clinician-scientist, and entrepreneur. Dr. Chao’s clinical focus is in the medical and surgical treatment of retinal diseases with a special interest in macular degeneration and diabetic retinopathy, retinal detachment, and inherited retinal diseases.
The event featured Dr. David S. Liao, a board-certified ophthalmologist at the Retina-Vitreous Associates Medical Group who specializes in the medical and surgical treatment of diseases of the retina and vitreous. Dr. Liao discussed the latest treatments to manage dry AMD and geographic atrophy, recent clinical trials, ways to slow the progression of vision loss, and how to maintain and improve quality of life after the diagnosis of a vision loss disease.
Our TOPPODCAST Picks 
